Back to top
more

iShares Virtual Work and Life Multisector ETF: (IWFH)

(Delayed Data from NYSE) As of Jul 26, 2024 01:11 PM ET

$15.23 USD

15.23
141

+0.23 (1.52%)

Volume: 141

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

Zacks News

Sanghamitra Saha headshot

Instacart Pops 12% On Nasdaq Debut: 6 ETFs in Focus

Instacart shares made their Nasdaq debut on Sep 19, 2023 with a 12% increase in their stock price.

Sanghamitra Saha headshot

Instacart's IPO Plans Put These ETFs in Focus

Instacart is targeting a valuation of roughly $8.6 billion to $9.3 billion in its imminent IPO.

Sweta Killa headshot

5 Sector ETFs That Beat the Market in December

December has been a brutal month for the U.S. stock market. The S&P 500 Index and the Dow Jones Industrial Index are down 5.8% and 4%, respectively, so far in December, while the tech-heavy Nasdaq Composite Index has lost 8.5%.

Sweta Killa headshot

Beaten-Down Tech ETFs to Buy This Holiday Season

According to the Consumer Technology Association (CTA), U.S. technology spending during the 2021 holiday season (October-December) is expected to reach a $142.5 billion, up 0.5% from last year.

Sweta Killa headshot

5 Bargain ETFs to Tap Renewed Tech Strength

The beaten down prices compelled investors to grab the technology stocks on cheap.

The Zacks Analyst Blog Highlights: ARKW, WCLD, IBUY, SUBZ, WFH and IWFH

The Zacks Analyst Blog Highlights: ARKW, WCLD, IBUY, SUBZ, WFH and IWFH

Sweta Killa headshot

Delta Variant to Spark Rally in Stay-At-Home ETFs

After declining sharply for six months, the COVID-19 infection has resurged across the United States and around the world thanks to the new Delta variant.

Sweta Killa headshot

JNJ Vaccine Pause Gives Stay-at-Home ETFs a Shot in the Arm

The U.S. regulators recommended an immediate pause on the use of Johnson & Johnson's (JNJ) COVID- 19 vaccine over reports of a "rare and severe type of blood clot" in six out of millions vaccinated.